NO930679L - Tetrahydrotiofenderivater - Google Patents

Tetrahydrotiofenderivater

Info

Publication number
NO930679L
NO930679L NO93930679A NO930679A NO930679L NO 930679 L NO930679 L NO 930679L NO 93930679 A NO93930679 A NO 93930679A NO 930679 A NO930679 A NO 930679A NO 930679 L NO930679 L NO 930679L
Authority
NO
Norway
Prior art keywords
residue
hydrogen
pharmaceutically acceptable
formula
acceptable salts
Prior art date
Application number
NO93930679A
Other languages
English (en)
Norwegian (no)
Other versions
NO930679D0 (no
Inventor
Shiro Mita
Yoichi Kawashima
Nobuharu Kato
Hiroshi Suhara
Koji Yoneda
Masataka Morishita
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO930679D0 publication Critical patent/NO930679D0/no
Publication of NO930679L publication Critical patent/NO930679L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Control Of Electric Motors In General (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Insulating Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO93930679A 1992-02-28 1993-02-25 Tetrahydrotiofenderivater NO930679L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7924992 1992-02-28

Publications (2)

Publication Number Publication Date
NO930679D0 NO930679D0 (no) 1993-02-25
NO930679L true NO930679L (no) 1993-08-30

Family

ID=13684588

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930679A NO930679L (no) 1992-02-28 1993-02-25 Tetrahydrotiofenderivater

Country Status (12)

Country Link
US (1) US5292767A (fr)
EP (1) EP0558287B1 (fr)
JP (1) JP2818919B2 (fr)
KR (1) KR930017877A (fr)
CN (1) CN1035876C (fr)
AT (1) ATE145902T1 (fr)
AU (1) AU648217B2 (fr)
CA (1) CA2090548A1 (fr)
DE (1) DE69306278T2 (fr)
FI (1) FI930873A7 (fr)
NO (1) NO930679L (fr)
TW (1) TW222629B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772783A (zh) * 2007-01-25 2012-11-14 中国生化制药工业协会 血清胸腺因子在制备抗肿瘤药物、肿瘤物理及化学治疗药物的保护药物方面的用途

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE202341T1 (de) * 1991-01-10 2001-07-15 Santen Pharmaceutical Co Ltd Cyclische verbindung
US5776859A (en) * 1995-11-15 1998-07-07 Nickel; Alfred A. Sodium channel active novel compounds and related processes and bioassay techniques
CN106831513A (zh) * 2017-01-06 2017-06-13 绍兴市上虞区耕创化工技术服务部 硫代乙酸钾的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE202341T1 (de) * 1991-01-10 2001-07-15 Santen Pharmaceutical Co Ltd Cyclische verbindung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772783A (zh) * 2007-01-25 2012-11-14 中国生化制药工业协会 血清胸腺因子在制备抗肿瘤药物、肿瘤物理及化学治疗药物的保护药物方面的用途

Also Published As

Publication number Publication date
EP0558287B1 (fr) 1996-12-04
US5292767A (en) 1994-03-08
AU3386093A (en) 1993-09-02
FI930873A0 (fi) 1993-02-26
CA2090548A1 (fr) 1993-08-29
JP2818919B2 (ja) 1998-10-30
DE69306278D1 (de) 1997-01-16
JPH05301867A (ja) 1993-11-16
KR930017877A (ko) 1993-09-20
TW222629B (fr) 1994-04-21
EP0558287A1 (fr) 1993-09-01
DE69306278T2 (de) 1997-04-17
FI930873A7 (fi) 1993-08-29
AU648217B2 (en) 1994-04-14
CN1035876C (zh) 1997-09-17
ATE145902T1 (de) 1996-12-15
CN1079739A (zh) 1993-12-22
NO930679D0 (no) 1993-02-25

Similar Documents

Publication Publication Date Title
ES8202546A1 (es) Metodo de producir derivados de tiazolidina
HU9400578D0 (en) Oxazolidinedion derivatives, their production and use
DE69330949D1 (de) Gaba und l-glutaminsaüre analoga zur behandlung der epilepsie
ES2159277T3 (es) Un derivado del pirrolidiltiocarbapenemo.
IL64905A (en) Process for the preparation of 2-penems,carbapenems,carbacephams,oxapenems,and azapenems,some novel such compounds and pharmaceutical compositions containing them
EP0096157A3 (en) Substituted acyl derivatives of 1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid
CA2318349A1 (fr) Oestrone sulfamate inhibant l'oestrone sulfatase, compositions pharmaceutiques associees et methodes d'utilisation
FI934626A0 (fi) Substituerade bensylaminokinuklidiner
NO931529L (no) Cykliske fruktopyranosesulfitter og -sulfater med antikonvulsiv effekt
FI921222A0 (fi) Aminoguanidiner.
DE69313427D1 (de) Hexahydronapththalinesterderivate, ihre Herstellung und ihre therapeutischen Verwendungen
IE872588L (en) Compounds
ATE34394T1 (de) Therapeutisch aktive di-, tri-, tetra- und penta- aza-indene.
SE8802402D0 (sv) Novel esters
ZA959436B (en) Smooth muscle cell proliferation inhibitors.
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
UA43338C2 (uk) Похідні бензолу
TW222629B (fr)
TW225989B (fr)
BG60248B2 (en) Process for the preparation of phenoxyethylamine derivatives
DE69303333D1 (de) Substituierte Benzoate-Derivate
AU2742288A (en) Novel compound effective as cerebral insufficiency improver
ATE186907T1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung
ATE25253T1 (de) 1,2-dithiol-3-on-derivate, ihre herstellung und diese enthaltende medizinische zusammenstellungen.
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.